Journal of Korean Academy of Dental Administration (대한치과의료관리학회지)

Korean Academy of Dental Administration (대한치과의료관리학회)
권호 표지
DOI QR코드

DOI QR Code

Oral bacterium Porphyromonas gingivalis, an upstream driver of dementia

치매유발 구강세균 진지발리스

  • Received : 2021.12.20
  • Accepted : 2021.12.22
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Carter CJ, France J, Crean S, Singhrao SK. The Porphyromonas gingivalis/host interactome shows enrichment in GWASdb genes related to Alzheimer's disease, diabetes and cardiovascular diseases. Front Aging Neurosci 2017;9:408. https://doi.org/10.3389/fnagi.2017.00408
  2. Choi S, Kim K, Chang J, Kim SM, Kim SJ, Cho HJ, et al. Association of chronic periodontitis on Alzheimer's disease or vascular dementia. J Am Geriatr Soc 2019;67(6):1234-9. https://doi.org/10.1111/jgs.15828
  3. de Oliveira Araujo R, Villoria GEM, Luiz RR, Esteves JC, Leao ATT, Feres-Filho EJ. Association between periodontitis and Alzheimer's disease and its impact on the self-perceived oral health status: a case-control study. Clin Oral Investig 2021;25(2):555-62. https://doi.org/10.1007/s00784-020-03489-w
  4. de Oliveira J, Kucharska E, Garcez ML, Rodrigues MS, Quevedo J, Moreno-Gonzalez I, et al. Inflammatory cascade in Alzheimer's disease pathogenesis: a review of experimental findings. Cells 2021;10(10):2581. https://doi.org/10.3390/cells10102581
  5. Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 2019;5(1):eaau3333. https://doi.org/10.1126/sciadv.aau3333
  6. Gosztyla ML, Brothers HM, Robinson SR. Alzheimer's amyloid-β is an antimicrobial peptide: a review of the evidence. J Alzheimers Dis 2018;62(4):1495-506. https://doi.org/10.3233/JAD-171133
  7. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991;12(10):383-8. https://doi.org/10.1016/0165-6147(91)90609-V
  8. Hussain B, Fang C, Chang J. Blood-brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia. Front Neurosci 2021;15:688090. https://doi.org/10.3389/fnins.2021.688090
  9. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (NY) 2018;4:575-90. https://doi.org/10.1016/j.trci.2018.06.014
  10. Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. Amyloid-b peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 2016;8(340):340ra72. https://doi.org/10.1126/scitranslmed.aaf1059
  11. Narengaowa, Kong W, Lan F, Awan UF, Qing H, Ni J. The oral-gut-brain AXIS: the influence of microbes in Alzheimer's disease. Front Cell Neurosci 2021;15:633735. https://doi.org/10.3389/fncel.2021.633735
  12. van de Guchte M, Blottiere HM, Dore J. Humans as holobionts: implications for prevention and therapy. Microbiome 2018;6(1):81. https://doi.org/10.1186/s40168-018-0466-8
  13. Vigasova D, Nemergut M, Liskova B, Damborsky J. Multi-pathogen infections and Alzheimer's disease. Microb Cell Fact 2021;20(1):25. https://doi.org/10.1186/s12934-021-01520-7
  14. Willis JR, Gabaldon T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms 2020;8(2):308. https://doi.org/10.3390/microorganisms8020308